Psychotropic properties of oxytocin

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Neuroscience and Behavioral Physiology

• Publication date

  1984-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/BF01186517PMID 6718333
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Behavior of Organisms

  1991cited by this paper
• Endorphins and behavior.

  1982cited by this paper
• Neural peptides and neuronal communication.

  1980cited by this paper
• Action of posterior pituitary neuropeptides on the nigrostriatal dopaminergic system.

  1979cited by this paper
• Chapter 8: Clinical Effects of Hypothalamic‐Pituitary Peptides on the Central Nervous System

  1978cited by this paper

• Intertwined associations between oxytocin, immune system and major depressive disorder

  2023cites this paper
• Exploring the role of neuropeptides in depression and anxiety.

  2021cites this paper
• Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies.

  2020cites this paper
• Oxytocin-functions: an overview

  2019cites this paper
• A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.

  2016cites this paper
• From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders

  2016cites this paper
• Autism‐relevant behaviors are minimally impacted by conditional deletion of Pten in oxytocinergic neurons

  2016cites this paper
• Potential of Oxytocin in the Treatment of Schizophrenia

  2016cites this paper
• Social Hormones and Human Behavior: What Do We Know and Where Do We Go from Here

  2015cites this paper
• Schizophrenia and alcohol dependence: diverse clinical effects of oxytocin and their evolutionary origins.

  2014cites this paper
• A meta-analysis and theoretical critique of oxytocin and psychosis: prospects for attachment and compassion in promoting recovery.

  2014cites this paper
• Evolutionary perspectives on the role of oxytocin in human social behavior, social cognition and psychopathology.

  2014cites this paper
• Oxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients

  2013cites this paper
• Title : The Role of Oxytocin in Psychiatric Disorders : A Review of Biological and Therapeutic Research Findings Activity

  2013cites this paper
• Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.

  2013cites this paper
• Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders

  2013cites this paper
• The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings.

  2013cites this paper
• Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree.

  2012cites this paper
• Oxytocin in schizophrenia: a review of evidence for its therapeutic effects

  2012cites this paper
• Biological correlates of women’s mood and orgasm

  2012cites this paper
• An investigation of the effects of oxytocin on social cognition and social functioning in schizophrenia

  2012cites this paper
• Prosocial effects of oxytocin and clinical evidence for its therapeutic potential.

  2011influential citation
• Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia.

  2011cites this paper
• The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans.

  2010cites this paper
• Peripheral oxytocin is associated with reduced symptom severity in schizophrenia.

  2010influential citation
• Behavioral effects of neuropeptides in rodent models of depression and anxiety.

  2010cites this paper
• Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

  2010cites this paper
• Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist.

  2010cites this paper